CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT06814210

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06814210
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06814210. Randomized; single masking; primary purpose prevention. Start 2025-03-01 (anticipated); primary completion 2025-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair
Condition
Mitral Regurgitation
Condition
Functional Mitral Regurgitation
Condition
Degenerative Mitral Valve Regurgitation
Intervention (Device)
Cerebral Embolic Protection
Lead sponsor
Xiao-dong Zhuang (class: other)

Record details

Record id
cardio:ct-nct06814210
Content hash
7a00b6da87da979efa50a552b6938b934d28068a0f10d90e6e3d44100b219172